National Cancer Institute Director Neil Sharpless says mortality from delays in cancer screenings due to COVID19 pandemic could result in tens of thousands of extra deaths in next decade Reporter: Stephen J Williams, PhD UPDATED: 10/11/2021 Source: https://cancerletter.com/articles/20200619_1/ NCI Director’s Report Sharpless: COVID-19 expected to increase mortality by at least 10,000 deaths from breast and […]
Search Results for 'Breast Cancer'
National Cancer Institute Director Neil Sharpless says mortality from delays in cancer screenings due to COVID19 pandemic could result in tens of thousands of extra deaths in next decade
Posted in Cancer - General, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Prevention: Research & Programs, Cancer Researchers Fighting COVID-19, Cancer Screening, coronavirus, Coronavirus Gene Expression, COVID-19: Pandemic Surgery Guidance, number of asymptomatic infections, Patient Experience, SARS-CoV-2, Treatment Protocols for COVID-19, tagged #COVID-19, #COVID19andcancer, breast cancer, breast cancer screening, colon cancer, colon cancer screening, coronavirus, COVID-19, NCI, SARS-CoV-2 on June 25, 2020| Leave a Comment »
NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese
Posted in Cancer - General, Cancer and Current Therapeutics, Cancer Informatics, Childhood cancer, Clinical & Translational, Curation, Global Medical Publishers by Country, Health Care System by Country, LPBI Management, Personal Health Applications: Tech Innovations serves HealhCare, Pharmaceutical Industry Competitive Intelligence, Pharmacovigilance, Population Health Management, Prostate Cancer: Monitoring vs Treatment, Scientific Publishing, tagged Brazil, breast cancer, Cancer, cancer treatment, Clinical decision support system, clinical trial guidelines, colon cancer, FDA, FDA guidance, Latin America, LPBI, Medical guideline, medical text, national cancer institute, National Comprehensive Cancer Network, NCCN, Regulatory, Spanish, translation, treatment decisions, treatment guidance on September 14, 2021| Leave a Comment »
NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese Reporter: Stephen J. Williams, Ph.D. Currently many biomedical texts and US government agency guidelines are only offered in English or only offered in different languages upon request. However Spanish is spoken in a majority of countries worldwide and medical text in that language […]
Ethics Behind Genetic Testing in Breast Cancer: A Webinar by Laura Carfang of survivingbreastcancer.org
Posted in Bio-Ethics, Ethics and Leadership, Genetics & Pharmaceutical, Health Economics and Outcomes Research, Healthcare costs and reimbursement, Healthcare Reform, Patient Experience, Patient Outlook, Patient-centered Medicine, Uncategorized, Women Health, tagged BRCA1/2 mutation, breast cancer, cancer patient management, cancer risk, defining patient experience, genetic counseling, genetic testing, patient advocacy on March 12, 2020| 1 Comment »
Ethics Behind Genetic Testing in Breast Cancer: A Webinar by Laura Carfang of survivingbreastcancer.org Reporter: Stephen J. Williams, PhD The following are Notes from a Webinar sponsored by survivingbreastcancer.org on March 12,2020. The webinar started with a brief introduction of attendees , most who are breast cancer survivors. Survivingbreastcancer.org is an organization committed to supplying […]
Showcase: How Deep Learning could help radiologists spend their time more efficiently
Posted in Artificial Intelligence - General, Artificial Intelligence Applications in Health Care, Artificial Intelligence in CANCER, Artificial Intelligence in Health Care - Tools & Innovations, Artificial Intelligence in Medicine - Application for Diagnosis, tagged breast cancer, Cancer - General, mammography breast cancer screening on August 22, 2019| Leave a Comment »
Showcase: How Deep Learning could help radiologists spend their time more efficiently Reporter and Curator: Dror Nir, PhD 3.5.2.3 Showcase: How Deep Learning could help radiologists spend their time more efficiently, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 3: AI in […]
Personalized Medicine, Omics, and Health Disparities in Cancer: Can Personalized Medicine Help Reduce the Disparity Problem?
Posted in and Bioethics, Big Data, Bio-Ethics, BioBanking, BioIT: BioInformatics, BioIT: BioInformatics, NGS, Clinical & Translational, Pharmaceutical R&D Informatics, Clinical Genomics, Cancer Informatics, Biomarkers & Medical Diagnostics, Breast Cancer - impalpable breast lesions, Cancer - General, Cancer and Current Therapeutics, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Genomics, Cancer Informatics, Cancer Prevention: Research & Programs, Cancer Screening, Centers for Medicare & Medicaid Services, Funding Opportunities for Cancer Research, Health Care System by Country, Health Economics and Outcomes Research, Health Law & Patient Safety, HealthCare IT, Healthcare Reform, interventional oncology, TP53 - Germline mutations, Women Health, tagged #endcancer, African diaspora, breast cancer, Cancer, cancer disparities, clinical genomics, diagnostic genomics, health disparities, men's health, ovarian cancer, sub Saharan, womens' health on April 19, 2020| 2 Comments »
Personalized Medicine, Omics, and Health Disparities in Cancer: Can Personalized Medicine Help Reduce the Disparity Problem? Curator: Stephen J. Williams, PhD In a Science Perspectives article by Timothy Rebbeck, health disparities, specifically cancer disparities existing in the sub-Saharan African (SSA) nations, highlighting the cancer incidence disparities which exist compared with cancer incidence in high income […]
Google’s Artificial Intelligence Algorithm Shows Improved Accuracy in Reading Mammograms
Posted in Artificial Intelligence - General, Artificial Intelligence Applications in Health Care, Artificial Intelligence in CANCER, Artificial Intelligence in Health Care - Tools & Innovations, Artificial Intelligence in Medicine - Application for Diagnosis, Breast Cancer - impalpable breast lesions, Cancer - General, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Screening, Deep Learning in Pathology, tagged AI, Artificial intelligence, breast cancer screening, deep learning, Digital pathology, Google, Google health, mammogram, pathologists, Pathology on January 2, 2020| Leave a Comment »
Google AI improves accuracy of reading mammograms, study finds Anne Stych, Staff Writer Jan 2, 2020, 10:28am EST Weinberg-Clark Photography Google CFO Ruth Porat has blogged about twice battling breast cancer. Artificial intelligence was often more accurate than radiologists in detecting breast cancer from mammograms in a study conducted by researchers using Google AI technology. […]